Organon N.V.
13 products tracked · names used in filings: Organon N.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 23 Apr 2026🇪🇺 EU approval (EC decision)
Poherdy (pertuzumab) approved in the EU
Marketing authorisation to Organon N.V.; Biosimilar, Additional monitoring · source
Thu 26 Feb 2026🇪🇺 CHMP positive opinion
Poherdy (pertuzumab): CHMP positive opinion
Organon N.V.; Biosimilar, Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Poherdy pertuzumab | Authorised | 2026-04-23 |
| 🇪🇺 | Ioa nomegestrol acetate;estradiol | Withdrawn | 2011-11-16 |
| 🇪🇺 | Sycrest asenapine | Authorised | 2010-09-01 |
| 🇪🇺 | Elonva corifollitropin alfa | Authorised | 2010-01-25 |
| 🇪🇺 | Vantavo (previously Alendronate sodium and colecalciferol, MSD) alendronic acid;colecalciferol | Authorised | 2009-10-16 |
| 🇪🇺 | Aerinaze desloratadine;pseudoephedrine | Authorised | 2007-07-30 |
| 🇪🇺 | Adrovance alendronic acid;colecalciferol | Authorised | 2007-01-04 |
| 🇪🇺 | Fosavance alendronic acid;colecalciferol | Authorised | 2005-08-24 |
| 🇪🇺 | Aerius desloratadine | Authorised | 2001-01-15 |
| 🇪🇺 | Azomyr desloratadine | Authorised | 2001-01-15 |
| 🇪🇺 | Neoclarityn desloratadine | Authorised | 2001-01-15 |
| 🇪🇺 | Orgalutran ganirelix | Authorised | 2000-05-16 |
| 🇪🇺 | Puregon follitropin beta | Authorised | 1996-05-02 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.